Tag: FDA

Congressman Brings Personal CBD Products to Educate on Hemp

A Republican congressman showcased two CBD products he personally uses at a congressional hearing last week, to demonstrate the differences between hemp and marijuana, in order to inform lawmakers about the “vaping epidemic”. During a House Oversight Committee meeting on the recent spike in vaping-related injuries, Rep. James Comer (R-KY) said he wanted to spend […]

Read More…

Washington State Bans CBD Infused Edibles

Washington state banned CBD-infused edibles and the commercial sale of food and beverages containing CBD, sticking closely to U.S. Food and Drug Administration (FDA) policy. The FDA currently stipulates that the cannabinoid cannot be an ingredient in the food supply, and the Washington State Department of Agriculture (WSDA) posted similar restrictions this month. “To be clear, […]

Read More…

FDA Sets Meeting to Decide CBD Regulations

Daily Leaf readers know how much we love CBD. This week, departing FDA Commissioner Scott Gottlieb released a statement outlining the agency’s future plans for the marketing and regulation of products that contain cannabidiol (CBD). The Commissioner provided a date for the much-anticipated public hearing concerning CBD regulations supplied more information on a working group […]

Read More…

FDA Promises to Give CBD Industry a Fair Shake

In a follow-up to hemp legalization being signed into law last month the U.S. Food and Drug Administration(FDA) issued a reminder that CBD and THC are still not legal to add to food – but promised further review of its guidelines. “It’s unlawful to introduce food containing added CBD or THC into interstate commerce, or to […]

Read More…

FDA Commission Says Federal Cannabis Action is Inevitable

Federal action on marijuana policy is inevitable and will happen “soon,” according to Food and Drug Administration (FDA) Commissioner Scott Gottlieb. Exactly what kind of action he’s anticipating is unclear, though. After dismissing the idea that botanical cannabis has therapeutic value, Gottlieb said in a CNBC appearance on Friday that there’s “probably going to be […]

Read More…

FDA Receives 20,000 Comments From Public on Classification of Cannabis

Recently, the Food and Drug Administration (FDA) requested public input on the international classification of marijuana and other drugs. Well, ask and you shall receive. More than 20,000 people submitted comments ahead of the Wednesday deadline. And about half of those were gathered and hand-delivered to FDA headquarters by NORML, which created an online tool to streamline […]

Read More…

Cannabis-Based Medicine Approved

The Food and Drug Administration(FDA) has finally approved a marijuana-based medication to treat two rare seizure conditions associated with developmental issues. The government agency gave the green light this week to an oral solution called Epidiolex to treat Lennox-Gastaut syndrome and Dravet syndrome in those ages 2 and up. The drug contains cannabidiol, or CBD, […]

Read More…

CBD-Based Pharma Drug Submitted To FDA For Approval

Will the FDA approve its first CBD-based drug? Epidiolex, a pharmaceutical made by UK-based company GW Pharmaceuticals plc (known as Greenwich Biosciences in the US), is a CBD-based drug that’s targeted specifically to patients who suffer seizures due to either Dravets syndrome or Lennox-Gastaut syndrome. The New Drug Application for Epidiolex was just submitted to the […]

Read More…